{"url":"https://whatshealthyandwhy.com/nad-plus/nad-plus-basics","path":"/nad-plus/nad-plus-basics","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/nad-plus/nad-plus-basics.json","markdown":"https://whatshealthyandwhy.com/nad-plus/nad-plus-basics.md"},"topic":{"slug":"nad-plus","name":"NAD+","url":"https://whatshealthyandwhy.com/nad-plus"},"slug":"nad-plus-basics","order":1,"title":"The Longevity Molecule: NAD+ and Cellular Energy","question":"Do NMN and NR supplements improve health or slow aging?","answer":"NMN and NR likely improve some muscle and metabolic measures, but trials are small and short, and anti-aging benefit is unproven.","description":"How NAD+ fuels your cells, declines with age, and why NMN and NR supplements are at the frontier of aging research","confidence":3,"confidenceNote":"Several double-blind trials in 12–80 people raised NAD+; the best clinical result is better muscle insulin sensitivity in 25 prediabetic women.","evidenceSummary":{"rctCount":4,"observationalCount":0,"metaAnalysisCount":0,"totalParticipants":"130+","replicated":true,"newestStudyYear":2023},"category":{"categoryTitle":"What's Good For You","categorySlug":"good-for-you","subcategoryName":"Supplements & Vitamins","subcategorySlug":"supplements","url":"https://whatshealthyandwhy.com/explore/good-for-you/supplements"},"actions":["Food first: niacin from meat, fish and legumes supplies some precursors, though far less than trial doses; edamame has small amounts of NMN.","Trials used 250–1,000 mg a day of NMN or NR; a dose-finding trial found 600 mg/day NMN best for NAD+ and performance [7].","Store NMN away from heat and light, and choose properly stored encapsulated or sublingual forms."],"cautions":["Safety data reach only about 12 weeks, so long-term effects of NMN or NR are unknown.","Several leading researchers have commercial ties to supplement companies, and proven anti-aging effects in humans have not been shown."],"simpleText":"NAD+ (nicotinamide adenine dinucleotide) is a molecule found in every cell of your body that acts as a fundamental fuel for cellular energy production, DNA repair, and longevity signaling. The problem is that NAD+ levels decline significantly with age — roughly 50% by middle age — and this decline is now recognized as a key driver of the metabolic slowdown and increased disease risk that come with aging [1]. Supplements like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors that the body converts into NAD+, and human clinical trials now show they can meaningfully raise NAD+ levels in blood and muscle [4][7].","mediumText":"How NAD+ Works\n\nNAD+ plays two essential roles in human biology: it powers your mitochondria and activates your longevity proteins.\n\nCellular Energy Production\n\nIn your mitochondria, NAD+ acts as an electron carrier in the process that converts glucose and fats into ATP — the energy currency your cells run on. Without adequate NAD+, this process becomes less efficient. This is why low NAD+ is associated with fatigue, reduced physical capacity, and metabolic sluggishness. Every cell in your body depends on it, but tissues with high energy demands — muscle, brain, heart — feel the impact of decline most acutely.\n\nSirtuins: Your Longevity Proteins\n\nNAD+ is the essential fuel for a family of proteins called sirtuins (SIRT1–SIRT7). Sirtuins regulate some of the most important processes in aging biology: DNA damage repair, inflammation control, mitochondrial quality, and cellular stress responses [1][2]. When NAD+ is abundant, sirtuins are active and protective. When NAD+ falls — as it does with age — sirtuin activity decreases, and the hallmarks of aging accelerate: accumulating DNA damage, chronic low-grade inflammation, declining mitochondrial function [3].\n\nDNA Repair Enzymes (PARPs)\n\nNAD+ is also consumed by PARP enzymes that repair DNA strand breaks. As we accumulate more DNA damage with age, PARPs become more active — competing with sirtuins for the same pool of NAD+. This creates a vicious cycle: more damage → more PARP activity → less NAD+ → less sirtuin activity → more damage.\n\nThe Age-Related Decline\n\nResearch shows NAD+ drops approximately 50% from young adulthood to middle age, and continues falling. This is due to several factors: decreased production via the NAD+ salvage pathway, increased consumption by PARPs and inflammatory enzymes (CD38), and reduced efficiency of the enzymes that recycle NAD+ [1]. Restoring NAD+ through precursor supplementation is the logic behind NMN and NR.\n\nNMN vs. NR: What's the Difference?\n\nBoth NMN and NR are NAD+ precursors — molecules the body converts into NAD+. They're both forms of vitamin B3 (niacin) derivatives, but they differ in their biochemical pathway and some practical aspects:\n\n- NR (Nicotinamide Riboside): Discovered earlier; more early human research available. Must be converted to NMN first before becoming NAD+. Absorbed orally and raises blood NAD+ dose-dependently [4].\n- NMN (Nicotinamide Mononucleotide): One step closer to NAD+ in the biosynthesis pathway. Has strong human RCT data for muscle insulin sensitivity, blood NAD+ elevation, and physical function [6][7][8].\n- Dose ranges: Most human trials use 250–1,000 mg/day for NMN or NR. A multicenter dose-finding trial found optimal effects at 600 mg/day NMN for NAD+ levels and physical performance markers [7].\n- Both are well-tolerated with no significant safety signals in trials up to 12 weeks at these doses.\n\nPractical Considerations\n\n- Who might benefit most: People over 40, those with metabolic conditions, people experiencing fatigue or reduced exercise capacity\n- Food sources of NAD+ precursors: Niacin (B3) from meat, fish, and legumes provides some precursors, but not in the concentrated amounts used in research trials; edamame contains NMN in small amounts\n- Timing: Most people take supplements in the morning since NAD+ is involved in energy metabolism\n- Combination considerations: NAD+ supplements are often combined with resveratrol (activates SIRT1 differently), and pterostilbene (a resveratrol analogue) has been studied alongside NR\n- Storage: NMN can degrade with heat and light; look for sublingual or encapsulated forms stored properly\n\nSee our PQQ page for another mitochondria-focused supplement that works through different mechanisms, and our Resveratrol page for more on sirtuin activation.","deepText":"Evidence Review\n\nFoundational Mechanistic Research\n\nThe 2014 review by Imai and Guarente (PMID 24786309), two of the leading researchers in NAD+ biology, established the conceptual framework: NAD+ levels fall substantially with aging across multiple tissues in both rodents and humans, and this decline impairs sirtuin activity, which in turn accelerates multiple aging phenotypes including metabolic dysfunction, inflammatory dysregulation, and mitochondrial decline. This paper remains the canonical reference for understanding why NAD+ decline matters.\n\nMouchiroud et al. (PMID 23870130), published in Cell in 2013, demonstrated in C. elegans that restoring NAD+ through supplementation activated sirtuin signaling, triggered mitochondrial stress responses via the unfolded protein response (UPR^mt), and extended lifespan. While animal data, this study established the mechanistic chain from NAD+ → sirtuins → longevity that underlies the entire field.\n\nCantó and Auwerx (PMID 22106091) provided a comprehensive mechanistic review of how NAD+ controls SIRT1 activity, which then deacetylates PGC-1α — the master regulator of mitochondrial biogenesis. This pathway connects NAD+ to mitochondrial number and quality, providing a mechanistic basis for why NAD+ decline affects physical capacity.\n\nHuman NR Trials\n\nTrammell et al. (PMID 27721479), published in Nature Communications in 2016, was the landmark first human trial of NR. In 12 healthy adults, a single dose of 1,000 mg NR raised whole-blood NAD+ by up to 2.7-fold within hours, with smaller but significant increases at 300 mg. This established that NR is orally bioavailable and effectively raises the NAD+ metabolome in humans. The study identified NAAD (nicotinic acid adenine dinucleotide) as a sensitive biomarker of NAD+ repletion.\n\nElhassan et al. [5], published in Cell Reports in 2019, conducted a placebo-controlled crossover RCT in 12 aged men using 1 g NR/day for 21 days. NR elevated the NAD+ metabolome in skeletal muscle, down-regulated energy-metabolism and mitochondrial gene pathways without changing mitochondrial bioenergetics, and lowered levels of circulating inflammatory cytokines. This is particularly relevant given that muscle is a primary site of age-related metabolic decline. Sample size was small (n=12), which is a significant limitation.\n\nHuman NMN Trials\n\nYoshino et al. (PMID 33888596), published in Science in 2021, is arguably the strongest human NMN trial to date. In a 10-week double-blind RCT of 25 postmenopausal prediabetic women (250 mg/day NMN), the NMN group showed a 25% improvement in insulin-stimulated muscle glucose disposal as measured by hyperinsulinemic-euglycemic clamp — the gold standard for measuring insulin sensitivity. NMN also upregulated expression of genes involved in muscle remodeling and glucose transport (including GLUT4). This is the first demonstration that NMN produces meaningful metabolic benefit in humans, not just NAD+ biomarker changes.\n\nYi et al. (PMID 36482258), published in GeroScience in 2023, was a multicenter double-blind RCT in 80 healthy middle-aged adults randomized to 300, 600, or 900 mg/day NMN or placebo for 60 days. All NMN groups showed significant increases in blood NAD+ compared to placebo. The 600 mg/day group showed the best combination of NAD+ elevation and physical performance improvements. Importantly, all doses were well-tolerated with no significant safety signals — providing the best available dose-safety data in humans to date.\n\nIgarashi et al. (PMID 35927255), published in NPJ Aging in 2022, conducted a double-blind RCT in healthy older men receiving NMN supplementation. NMN significantly raised whole-blood NAD+ and showed changes in muscle function metrics over the treatment period. This study from Imai's group (a leading NMN researcher with partial commercial conflicts of interest worth noting) adds to the growing human evidence base.\n\nOverall Evidence Assessment\n\nThe human evidence for NAD+ precursor supplementation is more robust than for most longevity-focused supplements. Multiple double-blind RCTs confirm that NMN and NR reliably raise NAD+ levels in blood and muscle at doses of 250–1,000 mg/day, with good tolerability. The most clinically meaningful human finding is improved muscle insulin sensitivity with NMN (Yoshino et al.), which is a hard metabolic endpoint rather than just a biomarker shift.\n\nLimitations to keep in mind: most human trials are small (12–80 participants), short (8–12 weeks), and not always designed to detect hard clinical endpoints like disease incidence or mortality. The mechanistic rationale is strong, but translating biomarker improvements into long-term health outcomes remains to be demonstrated in larger, longer trials. The field also has notable conflicts of interest, as several leading researchers have commercial ties to supplement companies. The evidence justifies cautious optimism — this is one of the more scientifically grounded areas of longevity supplementation — but it would be an overstatement to claim proven anti-aging effects in humans at this stage.","deepTruncated":false,"references":[{"id":"1","title":"NAD+ and Sirtuins in Aging and Disease","authors":"Imai S, Guarente L","year":2014,"journal":"Trends in Cell Biology","pmid":"24786309","url":"https://pubmed.ncbi.nlm.nih.gov/24786309/"},{"id":"2","title":"The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling","authors":"Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cantó C, Mottis A, Jo YS, Viswanathan M, Schoonjans K, Guarente L, Auwerx J","year":2013,"journal":"Cell","pmid":"23870130","url":"https://pubmed.ncbi.nlm.nih.gov/23870130/"},{"id":"3","title":"Targeting sirtuin 1 to improve metabolism: all you need is NAD+?","authors":"Cantó C, Auwerx J","year":2012,"journal":"Pharmacological Reviews","pmid":"22106091","url":"https://pubmed.ncbi.nlm.nih.gov/22106091/"},{"id":"4","title":"Nicotinamide Riboside Is Uniquely and Orally Bioavailable in Mice and Humans","authors":"Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li Z, Abel ED, Migaud ME, Brenner C","year":2016,"journal":"Nature Communications","pmid":"27721479","url":"https://pubmed.ncbi.nlm.nih.gov/27721479/"},{"id":"5","title":"Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures","authors":"Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, et al.","year":2019,"journal":"Cell Reports","pmid":"31412242","url":"https://pubmed.ncbi.nlm.nih.gov/31412242/"},{"id":"6","title":"Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women","authors":"Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, Sindelar M, Pietka T, Patterson BW, Imai SI, Klein S","year":2021,"journal":"Science","pmid":"33888596","url":"https://pubmed.ncbi.nlm.nih.gov/33888596/"},{"id":"7","title":"The Efficacy and Safety of β-Nicotinamide Mononucleotide (NMN) Supplementation in Healthy Middle-Aged Adults: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Dependent Clinical Trial","authors":"Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al.","year":2023,"journal":"GeroScience","pmid":"36482258","url":"https://pubmed.ncbi.nlm.nih.gov/36482258/"},{"id":"8","title":"Chronic Nicotinamide Mononucleotide Supplementation Elevates Blood Nicotinamide Adenine Dinucleotide Levels and Alters Muscle Function in Healthy Older Men","authors":"Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, et al.","year":2022,"journal":"NPJ Aging","pmid":"35927255","url":"https://pubmed.ncbi.nlm.nih.gov/35927255/"}],"wordCount":1388,"source":{"path":"src/content/topics/nad-plus/nad-plus-basics.md"},"citeAs":"“Do NMN and NR supplements improve health or slow aging?.” What's Healthy and Why. https://whatshealthyandwhy.com/nad-plus/nad-plus-basics","notice":"General information backed by peer-reviewed research, not medical advice."}